Impingement Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Musculoskeletal Disorder, By Diagnosis and Imaging Techniques, By Treatment Modalities, By End User, By Region and Competition, 2020-2030F

Description

Global Impingement Syndrome Market was valued at USD 8.12 Billion in 2024 and is expected to reach USD 12.51 Billion by 2030 with a CAGR of 7.43% during the forecast period. Impingement syndrome, also known as shoulder impingement, is a common musculoskeletal condition that affects millions of people worldwide. It occurs when the tendons in the shoulder become compressed or irritated, leading to pain, reduced range of motion, and functional limitations. The global impingement syndrome market, which includes diagnostics, treatments, and therapies for this condition, has witnessed significant growth in recent years. The impingement syndrome market comprises a range of products and services, including diagnostic tools such as X-rays, MRI scans, and physical examinations, as well as non-surgical and surgical treatments like physical therapy, corticosteroid injections, and minimally invasive procedures. Key factors driving the growth of this market include the rising incidence of impingement syndrome, increasing awareness about musculoskeletal disorders, and advancements in medical technology. The prevalence of impingement syndrome is on the rise globally, primarily due to aging populations and lifestyle factors such as poor posture and sedentary behavior. As more individuals seek medical attention for shoulder pain and discomfort, the demand for diagnosis and treatment options is growing. Minimally invasive surgical techniques have gained popularity in the treatment of impingement syndrome. Procedures like arthroscopy offer quicker recovery times and reduced post-operative pain compared to traditional open surgery, driving demand for these techniques. Regenerative therapies such as platelet-rich plasma (PRP) and stem cell therapy are emerging as potential treatments for impingement syndrome. These therapies aim to stimulate the body's natural healing processes, offering a less invasive and potentially more effective treatment option. The COVID-19 pandemic accelerated the adoption of telemedicine and remote monitoring in healthcare. These technologies have made it easier for patients to access consultations and follow-up care for impingement syndrome, providing a convenient and efficient healthcare solution. The global impingement syndrome market is poised for growth, driven by increasing awareness, advancements in medical technology, and a rising prevalence of the condition. While challenges such as reimbursement issues and competition exist, opportunities in personalized medicine, emerging markets, collaborative research, and digital health solutions offer a promising future for the market. As research and innovation continue to advance, the impingement syndrome market has the potential to provide better care and outcomes for patients worldwide.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 8.12 Billion
Market Size 2030	USD 12.51 Billion
CAGR 2025-2030	7.43%
Fastest Growing Segment	Medications
Largest Market	North America

Key Market Drivers

Rising Prevalence of Impingement Syndrome is Driving the Global Impingement Syndrome Market

Impingement syndrome, also known as shoulder impingement, is a common orthopedic condition that affects millions of people worldwide. This condition occurs when the tendons or bursa in the shoulder become compressed or irritated, leading to pain, limited range of motion, and decreased quality of life. In recent years, the global Impingement Syndrome market has witnessed significant growth due to the rising prevalence of this condition and the increasing demand for effective treatment options.

Impingement syndrome primarily affects the shoulder joint, making it a common orthopedic ailment. It is often seen in individuals who engage in repetitive overhead activities, such as athletes, manual laborers, and individuals who perform tasks that require constant shoulder use. The aging population also plays a significant role in the increasing prevalence of this condition, as degenerative changes in the shoulder joint can make individuals more susceptible to impingement. Moreover, lifestyle factors such as poor posture, sedentary habits, and obesity contribute to the development of Impingement Syndrome. As these risk factors become more prevalent in modern society, the number of people diagnosed with shoulder impingement continues to rise. According to a study, "Shoulder impingement syndrome: impingement view and arthrography study based on 100 cases", aprospective evaluation was conducted to assess the combination of shoulder impingement views and arthrography in patients with chronic shoulder pain. A total of 523 patients with chronic shoulder pain underwent X-rays using both conventional and impingement views. Among them, 100 patients (mean age 62) were found to have subacromial bony spurs on the impingement view and underwent arthrography. These patients were divided into two groups based on the degree of spur formation, specifically whether the spur size exceeded half the acromial width, measured from the outer margin to the acromioclavicular joint. Of the 100 subacromial spurs identified on the impingement view, only 18 were visible on the conventional view, as assessed by an independent radiologist. Arthrography revealed 35 cases of rotator cuff tears, and the size of the bony spur was significantly associated with the occurrence of rotator cuff tears (P < 0.02).

Key Market Challenges

Limited Awareness and Misdiagnosis

One of the most significant obstacles in the impingement syndrome market is the limited awareness of the condition, both among the general public and healthcare professionals. Many individuals experiencing shoulder or hip pain may not immediately recognize the symptoms as indicative of impingement syndrome, often attributing the discomfort to general wear and tear, muscle strain, or other non-specific causes. This lack of awareness can lead to delayed diagnoses and subsequent delays in appropriate treatment, which can worsen the condition and increase the complexity of treatment. Additionally, healthcare providers may overlook the symptoms as they may present similarly to other musculoskeletal disorders, such as tendonitis or rotator cuff injuries, further complicating the diagnosis. The absence of early intervention can lead to chronic pain, impaired mobility, and a greater risk of developing secondary complications, ultimately contributing to higher healthcare costs due to prolonged treatment and rehabilitation needs. Increased education and awareness, particularly among general practitioners and physical therapists, are essential for timely identification and intervention.

Key Market Trends

Technological Advancements

Technological advancements have revolutionized healthcare across the globe, and the field of orthopedics is no exception. One area where these advancements are making a significant impact is in the treatment and management of Impingement Syndrome. This condition, characterized by pain and restricted movement in the shoulder, has traditionally been treated through conservative measures like physical therapy and anti-inflammatory medications. However, the integration of innovative technologies into the medical field is now opening up new avenues for diagnosis and treatment, transforming the global Impingement Syndrome market. In January 2023, Orthofix Medical Inc. and SeaSpine Holdings Corporation have successfully completed their previously announced merger of equals, following approval from the stockholders of both companies during their respective special meetings. A remarkable 99% of SeaSpine common shares and 98% of Orthofix common shares were voted in favor of the merger.

The advent of high-resolution imaging technologies like magnetic resonance imaging (MRI) and ultrasound has greatly improved the accuracy of diagnosing Impingement Syndrome. These tools allow healthcare professionals to visualize the shoulder joint and surrounding tissues in detail, enabling more precise diagnosis and treatment planning. Three-dimensional modeling techniques have emerged as powerful tools in the diagnosis of Impingement Syndrome. By creating detailed 3D models of the shoulder joint, doctors can better understand the structural issues contributing to impingement and plan interventions accordingly.

Key Market Players

Bioventus LLC
Orthofix Medical Inc.
Breg, Inc.
ConMed Corporation
Ossur hf.
Arthrex, Inc.
Globus Medical, Inc.
NuVasive, Inc.
Stryker Corporation
Medtronic plc

Report Scope:

In this report, the Global Impingement Syndrome Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Impingement Syndrome Market, By Type of Musculoskeletal Disorder:

Osteoarthritis
Rheumatoid Arthritis
Osteoporosis
Back and Neck Pain
Shoulder Impingement Syndrome
Knee Pain and Disorders

Impingement Syndrome Market, By Diagnosis and Imaging Techniques:

X-ray
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT) Scan
Ultrasound
Arthroscopy
Others

Impingement Syndrome Market, By Treatment Modalities:

Medications
Surgical Interventions

Impingement Syndrome Market, By End User:

Hospitals & Clinics
Ambulatory Care Centers
Others

Impingement Syndrome Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Impingement Syndrome Market.

Available Customizations:

Global Impingement Syndrome market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Impingement Syndrome Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type of Musculoskeletal Disorder (Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Back and Neck Pain, Shoulder Impingement Syndrome, Knee Pain and Disorders, Hip Pain and Disorders, Trauma and Fracture, Sports Injuries, Others)
- 5.2.2. By Diagnosis and Imaging Techniques (X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Ultrasound, Arthroscopy, Others)
- 5.2.3. By Treatment Modalities (Medications and Surgical Interventions)
- 5.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America Impingement Syndrome Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type of Musculoskeletal Disorder
- 6.2.2. By Diagnosis and Imaging Techniques
- 6.2.3. By Treatment Modalities
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Impingement Syndrome Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type of Musculoskeletal Disorder
    - 6.3.1.2.2. By Diagnosis and Imaging Techniques
    - 6.3.1.2.3. By Treatment Modalities
    - 6.3.1.2.4. By End User
- 6.3.2. Canada Impingement Syndrome Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type of Musculoskeletal Disorder
    - 6.3.2.2.2. By Diagnosis and Imaging Techniques
    - 6.3.2.2.3. By Treatment Modalities
    - 6.3.2.2.4. By End User
- 6.3.3. Mexico Impingement Syndrome Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type of Musculoskeletal Disorder
    - 6.3.3.2.2. By Diagnosis and Imaging Techniques
    - 6.3.3.2.3. By Treatment Modalities
    - 6.3.3.2.4. By End User

7. Europe Impingement Syndrome Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type of Musculoskeletal Disorder
- 7.2.2. By Diagnosis and Imaging Techniques
- 7.2.3. By Treatment Modalities
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Impingement Syndrome Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type of Musculoskeletal Disorder
    - 7.3.1.2.2. By Diagnosis and Imaging Techniques
    - 7.3.1.2.3. By Treatment Modalities
    - 7.3.1.2.4. By End User
- 7.3.2. United Kingdom Impingement Syndrome Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type of Musculoskeletal Disorder
    - 7.3.2.2.2. By Diagnosis and Imaging Techniques
    - 7.3.2.2.3. By Treatment Modalities
    - 7.3.2.2.4. By End User
- 7.3.3. Italy Impingement Syndrome Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type of Musculoskeletal Disorder
    - 7.3.3.2.2. By Diagnosis and Imaging Techniques
    - 7.3.3.2.3. By Treatment Modalities
    - 7.3.3.2.4. By End User
- 7.3.4. France Impingement Syndrome Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type of Musculoskeletal Disorder
    - 7.3.4.2.2. By Diagnosis and Imaging Techniques
    - 7.3.4.2.3. By Treatment Modalities
    - 7.3.4.2.4. By End User
- 7.3.5. Spain Impingement Syndrome Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type of Musculoskeletal Disorder
    - 7.3.5.2.2. By Diagnosis and Imaging Techniques
    - 7.3.5.2.3. By Treatment Modalities
    - 7.3.5.2.4. By End User

8. Asia-Pacific Impingement Syndrome Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type of Musculoskeletal Disorder
- 8.2.2. By Diagnosis and Imaging Techniques
- 8.2.3. By Treatment Modalities
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Impingement Syndrome Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type of Musculoskeletal Disorder
    - 8.3.1.2.2. By Diagnosis and Imaging Techniques
    - 8.3.1.2.3. By Treatment Modalities
    - 8.3.1.2.4. By End User
- 8.3.2. India Impingement Syndrome Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type of Musculoskeletal Disorder
    - 8.3.2.2.2. By Diagnosis and Imaging Techniques
    - 8.3.2.2.3. By Treatment Modalities
    - 8.3.2.2.4. By End User
- 8.3.3. Japan Impingement Syndrome Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type of Musculoskeletal Disorder
    - 8.3.3.2.2. By Diagnosis and Imaging Techniques
    - 8.3.3.2.3. By Treatment Modalities
    - 8.3.3.2.4. By End User
- 8.3.4. South Korea Impingement Syndrome Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type of Musculoskeletal Disorder
    - 8.3.4.2.2. By Diagnosis and Imaging Techniques
    - 8.3.4.2.3. By Treatment Modalities
    - 8.3.4.2.4. By End User
- 8.3.5. Australia Impingement Syndrome Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type of Musculoskeletal Disorder
    - 8.3.5.2.2. By Diagnosis and Imaging Techniques
    - 8.3.5.2.3. By Treatment Modalities
    - 8.3.5.2.4. By End User

9. South America Impingement Syndrome Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type of Musculoskeletal Disorder
- 9.2.2. By Diagnosis and Imaging Techniques
- 9.2.3. By Treatment Modalities
- 9.2.4. By End User
- 9.2.5. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Impingement Syndrome Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type of Musculoskeletal Disorder
    - 9.3.1.2.2. By Diagnosis and Imaging Techniques
    - 9.3.1.2.3. By Treatment Modalities
    - 9.3.1.2.4. By End User
- 9.3.2. Argentina Impingement Syndrome Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type of Musculoskeletal Disorder
    - 9.3.2.2.2. By Diagnosis and Imaging Techniques
    - 9.3.2.2.3. By Treatment Modalities
    - 9.3.2.2.4. By End User
- 9.3.3. Colombia Impingement Syndrome Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type of Musculoskeletal Disorder
    - 9.3.3.2.2. By Diagnosis and Imaging Techniques
    - 9.3.3.2.3. By Treatment Modalities
    - 9.3.3.2.4. By End User

10. Middle East and Africa Impingement Syndrome Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type of Musculoskeletal Disorder
- 10.2.2. By Diagnosis and Imaging Techniques
- 10.2.3. By Treatment Modalities
- 10.2.4. By End User
- 10.2.5. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Impingement Syndrome Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type of Musculoskeletal Disorder
    - 10.3.1.2.2. By Diagnosis and Imaging Techniques
    - 10.3.1.2.3. By Treatment Modalities
    - 10.3.1.2.4. By End User
- 10.3.2. Saudi Arabia Impingement Syndrome Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type of Musculoskeletal Disorder
    - 10.3.2.2.2. By Diagnosis and Imaging Techniques
    - 10.3.2.2.3. By Treatment Modalities
    - 10.3.2.2.4. By End User
- 10.3.3. UAE Impingement Syndrome Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type of Musculoskeletal Disorder
    - 10.3.3.2.2. By Diagnosis and Imaging Techniques
    - 10.3.3.2.3. By Treatment Modalities
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Bioventus LLC
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Orthofix Medical Inc.
14.3. Breg, Inc.
14.4. ConMed Corporation
14.5. Ossur hf.
14.6. Arthrex, Inc.
14.7. Globus Medical, Inc.
14.8. NuVasive, Inc.
14.9. Stryker Corporation
14.10. Medtronic plc